Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival

• Niels H. H. Heegaard ,

  * E-mail: nhe@ssi.dk

  Affiliation Department of Clinical Biochemistry and Immunology, Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Mikkel West-Nørager,

  Affiliation Department of Clinical Biochemistry and Immunology, Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Julia T. Tanassi,

  Affiliation Department of Clinical Biochemistry and Immunology, Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Gunnar Houen,

  Affiliation Department of Clinical Biochemistry and Immunology, Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Lotte Nedergaard,

  Affiliation Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Claus Høgdall,

  Affiliation The Gynecological Clinic, The Juliane Marie Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Estrid Høgdall

  Affiliation Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

  ⨯